[Form 4] RB GLOBAL INC. Insider Trading Activity
Timothy J. O'Day, a director of RB Global Inc. (RBA), reported acquisitions on a Form 4 dated 09/18/2025 of dividend equivalent rights tied to deferred share units and restricted share units. The filing shows acquisitions of 6, 7, and 5 dividend equivalent rights (all exercisable or payable with the related underlying awards) with a reported price of $0. The entries reflect derivative reporting lines for dividend equivalents related to DSUs and 2024 and 2025 RSU grants, and the beneficial ownership following the transactions is shown as 52, 49, and 10 shares respectively. The Form 4 was signed by an attorney-in-fact on 09/22/2025.
- Timely and specific disclosure of acquisitions under Section 16 with transaction date 09/18/2025
- Clarifies nature of accrued dividend equivalents tied to DSUs and 2024/2025 RSU grants
- Shows beneficial ownership totals after the transactions (52, 49, 10) for transparency
- None.
Insights
TL;DR: Routine disclosure of accrued dividend equivalents by a director; procedural and governance transparency maintained.
The Form 4 shows the director acquired dividend equivalent rights on 09/18/2025 tied to existing deferred share units and RSU grants. Transaction code is "A" indicating acquisition and the recorded price is $0, consistent with accrued, non-cash dividend equivalents rather than open-market purchases. The filing was completed by one reporting person and executed via attorney-in-fact, indicating proper procedural handling. This disclosure aligns with Section 16 reporting obligations and provides investors with clarity about the director's award-related holdings.
TL;DR: Small, non-cash accruals of dividend equivalents; immaterial to company capital structure or market supply.
The reported amounts—6, 7 and 5 dividend equivalent rights—are contingent rights to the economic equivalent of common shares and become exercisable or payable with the underlying DSUs/RSUs. Each line shows the number of underlying common shares and a post-transaction beneficially owned figure of 52, 49 and 10 shares respectively. The $0 price reflects that these are accruals tied to equity awards, not market purchases. Given the scale of the amounts disclosed, there is no indication in the filing of a material market impact.